Undoubtedly, the upstream and downstream molecules of the PI3K/AKT/mTOR, JAK/STAT, and Hippo signaling pathways are potential targets for adenomyosis treatment (Figure 3). This evidence concerns the gene AKT1 and adenomyosis.